首页|某三甲医院双通道药品处方回顾性分析

某三甲医院双通道药品处方回顾性分析

扫码查看
目的 通过对泉州某三甲医院某院区双通道药品处方进行整合和分析,评价我院双通道药品的使用情况。方法 通过CHIS中国医院信息系统采集2021年1月至2023年10月门诊双通道药品使用情况。结果 双通道药品在我院的处方量逐年增加。其中风湿免疫系统药物处方量占比最高(30。2%),其次是抗肿瘤药(26。1%)、皮肤用药(15。9%)和内分泌系统药物(11。2%)。从处方金额来看,抗肿瘤药的处方金额最高,占处方总金额的43。7%。其次是风湿免疫系统药物、皮肤用药、呼吸系统药物和内分泌系统药物。结论 双通道政策满足了谈判药品的供应保障和临床使用等需求,提高了谈判药品的可及性。
Retrospective Analysis of"Double Channel"Prescriptions in Outpatients of a Class Ⅲ Grade A Hospital
OBJECTIVE To integrate and analyze the prescriptions of Double Channel in outpatient pharmacy of a Class Ⅲ Grade A hospital in Quanzhou City,and to evaluate the rationality of drug use by clinicians in our hos-pital.METHODS The use of"Double Channel"drugs in outpatient clinics from 2021 to October 2023 was collect-ed through CHIS Chinese Hospital Information System.RESULTS The prescription quantity of double-channel drugs in our hospital is increasing year by year.Among them,rheumatism and immune system drugs accounted for the highest proportion(30.2%),followed by antineoplastic drugs(26.1%),skin drugs(15.9%)and endocrine sys-tem drugs(11.2%).In terms of prescription amount,the prescription amount of antineoplastic drugs was the high-est,accounting for 43.7%of the total prescription amount,followed by rheumatoid immune system drugs,skin drugs,respiratory system drugs and endocrine system drugs.CONCLUSION The double-channel policy meets the needs of supply security and clinical use of negotiated drugs,and improves the accessibility of negotiated drugs.

Double ChannelNational medical insurance negotiation drugsMedical security

郑晓玲、陈喆鸣

展开 >

泉州市第一医院药剂科,福建泉州 362000

双通道药品 国谈药品 医保

2024

海峡药学
中国药学会福建分会

海峡药学

影响因子:0.643
ISSN:1006-3765
年,卷(期):2024.36(10)